CorMedix Statistics Share Statistics CorMedix has 74.43M
shares outstanding. The number of shares has increased by 21.42%
in one year.
Shares Outstanding 74.43M Shares Change (YoY) 21.42% Shares Change (QoQ) 11.78% Owned by Institutions (%) 36.38% Shares Floating 72.6M Failed to Deliver (FTD) Shares 2,409 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 10.05M, so 13.5% of the outstanding
shares have been sold short.
Short Interest 10.05M Short % of Shares Out 13.5% Short % of Float 13.64% Short Ratio (days to cover) 6.63
Valuation Ratios The PE ratio is -26.6 and the forward
PE ratio is 5.73.
CorMedix's PEG ratio is
0.4.
PE Ratio -26.6 Forward PE 5.73 PS Ratio 10.97 Forward PS 2.5 PB Ratio 0.01 P/FCF Ratio -9.4 PEG Ratio 0.4
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CorMedix.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position Current Ratio 0 Quick Ratio 0 Debt / Equity 0 Debt / EBITDA -0.03 Debt / FCF -0.01 Interest Coverage -614.1
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $679.25K Profits Per Employee $-280.16K Employee Count 64 Asset Turnover 0.37 Inventory Turnover 0.42
Taxes Income Tax -1.39M Effective Tax Rate 7.22%
Stock Price Statistics The stock price has increased by 176.37% in the
last 52 weeks. The beta is 1.71, so CorMedix's
price volatility has been higher than the market average.
Beta 1.71 52-Week Price Change 176.37% 50-Day Moving Average 12.51 200-Day Moving Average 10.65 Relative Strength Index (RSI) 35.34 Average Volume (20 Days) 2,148,496
Income Statement In the last 12 months, CorMedix had revenue of 43.47M
and earned -17.93M
in profits. Earnings per share was -0.3.
Revenue 43.47M Gross Profit 40.28M Operating Income -22.36M Net Income -17.93M EBITDA -18.83M EBIT -19.29M Earnings Per Share (EPS) -0.3
Full Income Statement Balance Sheet The company has 40.65M in cash and 517.01K in
debt, giving a net cash position of 40.13M.
Cash & Cash Equivalents 40.65M Total Debt 517.01K Net Cash 40.13M Retained Earnings -339.63B Total Assets 149.58M Working Capital 110.47M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -50.61M
and capital expenditures -115.73K, giving a free cash flow of -50.73M.
Operating Cash Flow -50.61M Capital Expenditures -115.73K Free Cash Flow -50.73M FCF Per Share -0.86
Full Cash Flow Statement Margins Gross margin is 92.66%, with operating and profit margins of -51.43% and -41.24%.
Gross Margin 92.66% Operating Margin -51.43% Pretax Margin -44.45% Profit Margin -41.24% EBITDA Margin -43.32% EBIT Margin -51.43% FCF Margin -116.7%
Dividends & Yields CRMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CRMD is $17,
which is 69% higher than the current price. The consensus rating is "Buy".
Price Target $17 Price Target Difference 69% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 26, 2019. It was a
backward
split with a ratio of 1:5.
Last Split Date Mar 26, 2019 Split Type backward Split Ratio 1:5
Scores Altman Z-Score 12.75 Piotroski F-Score 4
